Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years

被引:61
作者
Filardo, Giuseppe [1 ]
Kon, Elizaveta [2 ]
Di Matteo, Berardo [1 ]
Di Martino, Alessandro [1 ]
Tesei, Giulia [1 ]
Pelotti, Patrizia [3 ]
Cenacchi, Annarita [4 ]
Marcacci, Maurilio [1 ]
机构
[1] Rizzoli Orthopaed Inst, Biomech & Technol Innovat Lab, Orthopaed & Traumatol Clin 2, I-40136 Bologna, Italy
[2] Rizzoli Orthopaed Inst, Nanobiotechnol Lab, I-40136 Bologna, Italy
[3] Rizzoli Orthopaed Inst, Radiol & Diagnost Imaging Dept, I-40136 Bologna, Italy
[4] Rizzoli Orthopaed Inst, Immunohaematol & Transfus Med Serv, I-40136 Bologna, Italy
关键词
PRP; growth factors; Achilles tendinopathy; injections; long term; TENDON REPAIR; REGENERATION; OUTCOMES; ANKLE; FOOT;
D O I
10.2450/2014.0289-13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Chronic Achilles tendinopathy is responsible for a severe reduction in physical performance and persistent pain. There is currently a number of therapeutic options and the local administration of growth factors is an emerging treatment strategy. In particular, platelet-rich plasma (PRP) is a widely used way to provide a local regenerative stimulus for tendon healing. The aim of this study was to document the mid-term results obtained after treating recalcitrant Achilles tendinopathy with injections of high concentrate, leucocyte-rich PRP. Materials and methods. Twenty-seven patients (mean age: 44.6 years; 22 men and 5 women) affected by chronic mid-portion Achilles tendinopathy (7 bilateral, for a total of 34 tendons), refractory to previous treatments, were enrolled. Patients were treated with three ultrasound-guided intra-tendinous injections of PRP at 2-week intervals. Patients were prospectively evaluated at baseline, and then at 2, 6, and up to a mean of 54.1 months of follow-up (minimum 30 months), using the following tools: Blanzina, VISA-A, EQ-VAS for general health, and Tegner scores. Results. The VISA-A score showed a significant improvement: the baseline score of 49.9 +/- 18.1 increased to 62.9 +/- 19.8 at 2 months (p=0.002), with a further improvement at 6 months (84.3 +/- 17.1, p<0.0005), and stable results at 4.5 years (90.0 +/- 13.9). The EQ-VAS score also showed a similar positive trend. An evaluation of the activity level confirmed these findings, showing a significant improvement in the Tegner score over time (p=0.017 for the final evaluation). The longer duration of symptoms before treatment was associated with a slower return to sport (p=0.041). Discussion. PRP injections produced good overall results for the treatment of chronic recalcitrant Achilles tendinopathy with a stable outcome up to a medium-term follow-up. Longer symptom duration was related with a more difficult return to sporting activity.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 41 条
[1]   The Effectiveness of Extracorporeal Shock Wave Therapy on Chronic Achilles Tendinopathy: A Systematic Review [J].
Al-Abbad, Hani ;
Simon, Joel Varghese .
FOOT & ANKLE INTERNATIONAL, 2013, 34 (01) :33-41
[2]   Platelet concentrate injection improves Achilles tendon repair in rats [J].
Aspenberg, P ;
Virchenko, O .
ACTA ORTHOPAEDICA SCANDINAVICA, 2004, 75 (01) :93-99
[3]   Influence of dosage and timing of application of platelet-derived growth factor on early healing of the rat medial collateral Ligament [J].
Batten, ML ;
Hansen, JC ;
Dahners, LE .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1996, 14 (05) :736-741
[4]   Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms [J].
Borzini, P ;
Mazzucco, L .
TRANSFUSION, 2005, 45 (11) :1759-1767
[5]   Effects of Platelet-Rich Plasma on the Quality of Repair of Mechanically Induced Core Lesions in Equine Superficial Digital Flexor Tendons: A Placebo-Controlled Experimental Study [J].
Bosch, Gerco ;
van Schie, Hans T. A. ;
de Groot, Mark W. ;
Cadby, Jennifer A. ;
van de Lest, Chris H. A. ;
Barneveld, Ab ;
van Weeren, P. Rene .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2010, 28 (02) :211-217
[6]   Platelet-Rich Plasma: A Milieu of Bioactive Factors [J].
Boswell, Stacie G. ;
Cole, Brian J. ;
Sundman, Emily A. ;
Karas, Vasili ;
Fortier, Lisa A. .
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2012, 28 (03) :429-439
[7]   Platelet-Rich Plasma: Where Are We Now and Where Are We Going? [J].
Cole, Brian J. ;
Seroyer, Shane T. ;
Filardo, Giuseppe ;
Bajaj, Sarvottam ;
Fortier, Lisa A. .
SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2010, 2 (03) :203-210
[8]   Incidence of midportion Achilles tendinopathy in the general population [J].
de Jonge, S. ;
van den Berg, C. ;
de Vos, R. J. ;
van der Heide, H. J. L. ;
Weir, A. ;
Verhaar, J. A. N. ;
Bierma-Zeinstra, S. M. A. ;
Tol, J. L. .
BRITISH JOURNAL OF SPORTS MEDICINE, 2011, 45 (13) :1026-1028
[9]   One-Year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy A Double-Blind Randomized Placebo-Controlled Trial [J].
de Jonge, Suzan ;
de Vos, Robert J. ;
Weir, Adam ;
van Schie, Hans T. M. ;
Bierma-Zeinstra, Sita M. A. ;
Verhaar, Jan A. N. ;
Weinans, Harrie ;
Tol, Johannes L. .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2011, 39 (08) :1623-1629
[10]   Can platelet-rich plasma enhance tendon repair? A cell culture study [J].
de Mos, Marieke ;
van der Windt, Anna E. ;
Jahr, Holger ;
van Schie, Hans T. M. ;
Weinans, Harrie ;
Verhaar, Jan A. N. ;
van Osch, Gerjo J. V. M. .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2008, 36 (06) :1171-1178